[go: up one dir, main page]

AR038575A1 - Formulacion oftalmica con nueva composicion de goma - Google Patents

Formulacion oftalmica con nueva composicion de goma

Info

Publication number
AR038575A1
AR038575A1 ARP030100557A ARP030100557A AR038575A1 AR 038575 A1 AR038575 A1 AR 038575A1 AR P030100557 A ARP030100557 A AR P030100557A AR P030100557 A ARP030100557 A AR P030100557A AR 038575 A1 AR038575 A1 AR 038575A1
Authority
AR
Argentina
Prior art keywords
ophthalm
formulation
rubber composition
new rubber
eye
Prior art date
Application number
ARP030100557A
Other languages
English (en)
Inventor
Satish Singh
Paramita Bandyopadhyay
Original Assignee
Pharmacia Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Corp filed Critical Pharmacia Corp
Publication of AR038575A1 publication Critical patent/AR038575A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Una composición farmacéutica adecuada para administrar por vía tópica sobre el ojo, que comprende: (a) una concentración efectiva para el uso farmacológico de un agente activo; y (b) una combinación de al menos dos polímeros compatibles para el uso oftálmico que comprende un nuevo sistema de goma. En realizaciones preferidas de la presente, las composiciones incrementan el tiempo de retención del agente activo en el ojo, en comparación con otras gomas o sistemas de gomas.
ARP030100557A 2002-02-22 2003-02-20 Formulacion oftalmica con nueva composicion de goma AR038575A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US35876102P 2002-02-22 2002-02-22

Publications (1)

Publication Number Publication Date
AR038575A1 true AR038575A1 (es) 2005-01-19

Family

ID=27765988

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030100557A AR038575A1 (es) 2002-02-22 2003-02-20 Formulacion oftalmica con nueva composicion de goma

Country Status (10)

Country Link
US (1) US7128928B2 (es)
EP (1) EP1476135A1 (es)
JP (1) JP2005521690A (es)
AR (1) AR038575A1 (es)
AU (1) AU2003213210A1 (es)
BR (1) BR0307893A (es)
CA (1) CA2477044A1 (es)
MX (1) MXPA04008171A (es)
TW (1) TW200400055A (es)
WO (1) WO2003072081A1 (es)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6565882B2 (en) 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US6541014B2 (en) 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US20090215735A1 (en) * 2002-02-25 2009-08-27 Alcon, Inc. Topical solution formulations containing a corticosteroid and a cyclodextrin
AU2004249137B2 (en) * 2003-06-13 2010-03-11 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of two polymers
US7947295B2 (en) * 2003-06-13 2011-05-24 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of two polymers
TWI336257B (en) * 2003-06-13 2011-01-21 Alcon Inc Ophthalmic compositions containing a synergistic combination of three polymers
US7914803B2 (en) * 2003-06-13 2011-03-29 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of three polymers
US6933289B2 (en) * 2003-07-01 2005-08-23 Allergan, Inc. Inhibition of irritating side effects associated with use of a topical ophthalmic medication
EP1648407A4 (en) 2003-07-21 2011-08-31 Middlebrook Pharmaceuticals Inc ANTIBIOTIC PRODUCT, CORRESPONDING USE AND FORMULATION
EP1648415A4 (en) 2003-07-21 2011-11-16 Middlebrook Pharmaceuticals Inc ANTIBIOTIC PRODUCT, ITS USE AND FORMULATION
CA2533358C (en) 2003-07-21 2014-03-11 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
US8758820B2 (en) 2003-08-11 2014-06-24 Shionogi Inc. Robust pellet
CA2535398C (en) 2003-08-12 2013-11-12 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
CA2535780A1 (en) 2003-08-29 2005-03-17 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
EP1663169A4 (en) 2003-09-15 2010-11-24 Middlebrook Pharmaceuticals In ANTIBIOTICS, ITS USE AND FORMULATION
AU2004305539B2 (en) * 2003-12-11 2010-09-02 Alcon, Inc. Ophthalmic compositions containing a polysaccharide/borate gelling system
US20070020299A1 (en) 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
JP2007525515A (ja) * 2004-02-26 2007-09-06 ボーシュ アンド ローム インコーポレイティド アルギネートの粘弾性組成物、その使用法及びパッケージ
SI1574221T1 (sl) * 2004-03-10 2007-10-31 Shimoda Biotech Pty Ltd Stabilni sestavki diklofenaka za vbrizgavanje
EP2127655A1 (en) * 2004-03-25 2009-12-02 Bausch & Lomb Incorporated Use of loteprednol etabonate for the treatment of dry eye
US20050215516A1 (en) * 2004-03-29 2005-09-29 Claudio Bucolo New free-radical scavenger containing viscoelastic composition, methods of use and package
WO2006014427A1 (en) 2004-07-02 2006-02-09 Advancis Pharmaceutical Corporation Tablet for pulsed delivery
JP4954076B2 (ja) * 2004-10-01 2012-06-13 メニコン シンガポール ピーティーイー． リミテッド コンタクトレンズ包装容器溶液
US20060134060A1 (en) * 2004-12-22 2006-06-22 Erning Xia Ophthalmic compositions comprising Aloe Vera
EP1899331B1 (en) 2005-06-29 2009-11-25 Pharmacia & Upjohn Company LLC Homomorpholine oxazolidinones as antibacterial agents
US20070004672A1 (en) * 2005-07-01 2007-01-04 Dharmendra Jani Long lasting alginate dry eye, related methods of manufacture and methods of use
US20070225217A1 (en) 2005-11-09 2007-09-27 Combinatorx, Incorporated Methods, compositions, and kits for the treatment of medical conditions
US20070110812A1 (en) * 2005-11-14 2007-05-17 Bausch & Lomb Incorporated Ophthalmic composition for dry eye therapy
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8778924B2 (en) 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US20100130580A1 (en) * 2006-01-25 2010-05-27 Aciex Therapeutics, Inc. Formulations and Methods for Treating Dry Eye
US20090010850A1 (en) * 2007-05-24 2009-01-08 Ousler Iii George W Formulations and methods for treating dry eye
AU2007208054A1 (en) * 2006-01-25 2007-08-02 Aciex Therapeutics, Inc. Formulations and methods for treating dry eye
WO2007112272A2 (en) * 2006-03-28 2007-10-04 Javelin Pharmaceuticals, Inc. Formulations of low dose diclofenac and beta-cyclodextrin
US8299052B2 (en) 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
WO2008088612A1 (en) * 2006-12-20 2008-07-24 Bausch & Lomb Incorporated Method of stimulating the production of mucin in the eye of a patient
US7659259B2 (en) * 2006-12-21 2010-02-09 Bausch & Lomb Incorporated Method of treating inflammation of the eye
WO2008082948A2 (en) * 2006-12-29 2008-07-10 Bausch & Lomb Incorporated Ophthalmic alginate composition related methods of manufacture and methods of use
JP5431965B2 (ja) * 2007-02-09 2014-03-05 アルコン，インコーポレイテッド ３種のポリマーの相乗的組み合わせを含む眼科用組成物
EP2155162B1 (en) * 2007-05-04 2012-11-21 Bausch & Lomb Incorporated Compositions for reducing, ameliorating, treating, or preventing condition of dry eye and methods of making and using same
US20080280853A1 (en) * 2007-05-07 2008-11-13 Erning Xia Compositions for reducing, ameliorating, treating, or preventing condition of dry eye and methods of making and using same
ES2493641T3 (es) * 2007-06-28 2014-09-12 Cydex Pharmaceuticals, Inc. Administración nasal de soluciones acuosas de corticosteroides
US9096819B2 (en) 2008-01-31 2015-08-04 Bausch & Lomb Incorporated Ophthalmic compositions with an amphoteric surfactant and an anionic biopolymer
US20110046033A1 (en) 2008-01-31 2011-02-24 Jinzhong Zhang Multipurpose Lens Care Solution with Benefits to Corneal Epithelial Barrier Function
US9481856B2 (en) * 2008-06-09 2016-11-01 Bausch & Lomb Incorporated Pharmaceutical formulations comprising stabilized polysaccharides and source of hydrogen peroxide
JP2011522863A (ja) * 2008-06-12 2011-08-04 ノバルティス アーゲー 眼の前部に対する持続送達としてのインサイチュゲル化システム
CA2736380C (en) * 2008-09-15 2013-05-28 Bausch & Lomb Incorporated Compositions comprising polymers having amino sugar units and methods of making and using same
US20100087550A1 (en) 2008-10-06 2010-04-08 Zora Marlowe Formulations with a Tertiary Amine Oxide
US8778999B2 (en) 2009-03-05 2014-07-15 Insite Vision Incorporated Non-steroidal anti-inflammatory ophthalmic compositions
WO2010118340A1 (en) * 2009-04-09 2010-10-14 University Of Medicine And Dentistry Of New Jersey Treatment of cutaneous hemangioma
BR112012013503B8 (pt) 2009-12-03 2021-05-25 Alcon Res Llc composição de suspensão oftálmica aquosa topicamente administrável, e método para manter sua viscosidade
US20130165419A1 (en) * 2011-12-21 2013-06-27 Insite Vision Incorporated Combination anti-inflammatory ophthalmic compositions
TW201336527A (zh) * 2012-02-10 2013-09-16 Alcon Res Ltd 具增強的穩定性之水性藥學組成物
JP6207291B2 (ja) * 2013-08-07 2017-10-04 大同化成工業株式会社 外用剤用組成物
US10052313B2 (en) * 2013-08-28 2018-08-21 Presbyopia Therapies, LLC Compositions and methods for the treatment of presbyopia
US10959990B2 (en) * 2013-08-28 2021-03-30 Presbyopia Therapies, Inc Compositions and methods for the treatment of presbyopia
US10350232B1 (en) 2013-11-04 2019-07-16 Peter D. Jaillet Medicinal drops
WO2017066964A1 (en) 2015-10-22 2017-04-27 Merck Sharp & Dohme Corp. Oxazolidinone compounds and methods of use thereof as antibacterial agents
US11576973B2 (en) 2015-10-25 2023-02-14 Iview Therapeutics, Inc. Pharmaceutical formulations that form gel in situ
US20210251970A1 (en) 2018-10-10 2021-08-19 Presbyopia Therapies Inc Compositions and methods for storage stable ophthalmic drugs
WO2023091439A1 (en) 2021-11-17 2023-05-25 Lenz Therapeutics, Inc. Aceclidine derivatives, compositions thereof and methods of use thereof
US11648247B1 (en) 2021-12-16 2023-05-16 Lenz Therapeutics, Inc. Compositions and methods for the treatment of presbyopia

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4136173A (en) * 1977-01-31 1979-01-23 American Home Products Corp. Mixed xanthan gum and locust beam gum therapeutic compositions
US4136177A (en) * 1977-01-31 1979-01-23 American Home Products Corp. Xanthan gum therapeutic compositions
US4136178A (en) * 1977-01-31 1979-01-23 American Home Products Corp. Locust bean gum therapeutic compositions
SE8305864D0 (sv) * 1983-10-25 1983-10-25 L E Medical Ogondroppar
DE3346123A1 (de) 1983-12-21 1985-06-27 Janssen Pharmaceutica, N.V., Beerse Pharmazeutische praeparate von in wasser schwerloeslichen oder instabilen arzneistoffen und verfahren zu ihrer herstellung
US4727064A (en) * 1984-04-25 1988-02-23 The United States Of America As Represented By The Department Of Health And Human Services Pharmaceutical preparations containing cyclodextrin derivatives
US4676976A (en) * 1985-03-08 1987-06-30 Ajinomoto Co., Inc. Konjak mannan-containing reversible gel
FR2588189B1 (fr) * 1985-10-03 1988-12-02 Merck Sharp & Dohme Composition pharmaceutique de type a transition de phase liquide-gel
DE3704907A1 (de) * 1987-02-17 1988-08-25 Bayer Ag Topisch anwendbare zubereitungen von gyrase-inhibitoren in kombination mit kortikosteroiden
NZ226171A (en) 1987-09-18 1990-06-26 Ethicon Inc Gel formulation containing polypeptide growth factor
US5843156A (en) * 1988-08-24 1998-12-01 Endoluminal Therapeutics, Inc. Local polymeric gel cellular therapy
US5135920A (en) * 1988-11-16 1992-08-04 Takeda Chemical Industries, Ltd. Angiostatic agents
US5521222A (en) * 1989-09-28 1996-05-28 Alcon Laboratories, Inc. Topical ophthalmic pharmaceutical vehicles
FR2653021A1 (fr) 1989-10-17 1991-04-19 Merck Sharp & Dohme Composition ophtalmique aqueuse liquide a transition de phase liquide-gel.
KR0166088B1 (ko) * 1990-01-23 1999-01-15 . 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
US5376645A (en) * 1990-01-23 1994-12-27 University Of Kansas Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
US5369095A (en) * 1990-02-14 1994-11-29 Alcon Laboratories, Inc. Compositions and method comprising substituted glycosides as mucus membrane permeation enhancers
US5227372A (en) * 1990-03-07 1993-07-13 Children's Medical Center Corporation Method for retaining ophthalmological agents in ocular tissues
EP0495421B1 (en) * 1991-01-15 1996-08-21 Alcon Laboratories, Inc. Use of carrageenans in topical ophthalmic compositions
US5212162A (en) * 1991-03-27 1993-05-18 Alcon Laboratories, Inc. Use of combinations gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions
US5318780A (en) * 1991-10-30 1994-06-07 Mediventures Inc. Medical uses of in situ formed gels
WO1993017664A1 (en) 1992-03-02 1993-09-16 Alcon Laboratories, Inc. Combinations of cellulosic polymers and carboxy vinyl polymers and their use in pharmaceutical compositions
IL105553A (en) 1992-05-06 1998-01-04 Janssen Pharmaceutica Inc Solid dosage forms consisting of a porous network of matrix that releases a substance that dissipates rapidly in water
NO304832B1 (no) * 1992-05-27 1999-02-22 Ube Industries Aminokinolonderivater samt middel mot HIV
US5358706A (en) 1992-09-30 1994-10-25 Union Carbide Chemicals & Plastics Technology Corporation Muco-adhesive polymers
JPH06345653A (ja) * 1993-06-08 1994-12-20 Asahi Chem Ind Co Ltd 点眼液
US5631004A (en) * 1993-09-30 1997-05-20 Alcon Laboratories, Inc. Use of sustained release antibiotic compositions in ophthalmic surgical procedures
SE9401109D0 (sv) * 1994-03-31 1994-03-31 Leiras Oy Opthalmic composition II
SE9401108D0 (sv) * 1994-03-31 1994-03-31 Leiras Oy Ophthalmic composition I
IL114193A (en) * 1994-06-20 2000-02-29 Teva Pharma Ophthalmic pharmaceutical compositions based on sodium alginate
TW434023B (en) 1995-09-18 2001-05-16 Novartis Ag Preserved ophthalmic composition
AU1558597A (en) 1996-02-07 1997-08-28 Rohto Pharmaceutical Co., Ltd. Ophthalmic composition with regulated viscosity
JP2000508312A (ja) * 1996-04-11 2000-07-04 ファルマシア・アンド・アップジョン・カンパニー オキサゾリジノンの製法
CA2257303C (en) * 1996-06-17 2006-04-04 Janssen Pharmaceutica N.V. Biconvex rapidly disintegrating dosage forms
US5888493A (en) * 1996-12-05 1999-03-30 Sawaya; Assad S. Ophthalmic aqueous gel formulation and related methods
GB9707934D0 (en) 1997-04-18 1997-06-04 Danbiosyst Uk Improved delivery of drugs to mucosal surfaces
US5874418A (en) * 1997-05-05 1999-02-23 Cydex, Inc. Sulfoalkyl ether cyclodextrin based solid pharmaceutical formulations and their use
US6046177A (en) * 1997-05-05 2000-04-04 Cydex, Inc. Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations
ES2210769T3 (es) * 1997-06-13 2004-07-01 Cydex Inc. Compuesto con vida de almacenamiento prolongada que comprende ciclodextrina y medicamentos y promedicamentos que se descomponen en componentes insolubles en agua.
GB9714102D0 (en) * 1997-07-04 1997-09-10 Ciba Geigy Ag Compounds
JP3979783B2 (ja) 1997-07-29 2007-09-19 アルコン ラボラトリーズ インコーポレイテッド ガラクトマンナンポリマー及びホウ酸塩を含む眼科組成物
NZ504372A (en) 1997-11-07 2002-12-20 Upjohn Co Process to produce N-[3-fluoro-4(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinones
AU2798299A (en) 1998-02-27 1999-09-15 Althexis Company, The Therapeutic and prophylactic uses of negatively charged substituted disaccharides
US6174524B1 (en) * 1999-03-26 2001-01-16 Alcon Laboratories, Inc. Gelling ophthalmic compositions containing xanthan gum
US6552024B1 (en) 1999-01-21 2003-04-22 Lavipharm Laboratories Inc. Compositions and methods for mucosal delivery
MXPA02000270A (es) 1999-07-06 2002-06-21 Procter & Gamble Hoja de gel preformada.
DE60030300T2 (de) * 1999-09-13 2007-08-30 Insite Vision, Inc., Alameda Topische behandlung zur vorbeugung von augeninfektionen
GB2363386B (en) 2000-06-16 2004-07-28 Chesham Chemicals Ltd Fluid gel comprising xanthan and non-gelling polysaccharides
PE20020578A1 (es) * 2000-10-10 2002-08-14 Upjohn Co Una composicion de antibiotico topico para el tratamiento de infecciones oculares

Also Published As

Publication number Publication date
JP2005521690A (ja) 2005-07-21
US20030232089A1 (en) 2003-12-18
TW200400055A (en) 2004-01-01
MXPA04008171A (es) 2004-11-26
CA2477044A1 (en) 2003-09-04
EP1476135A1 (en) 2004-11-17
WO2003072081A1 (en) 2003-09-04
BR0307893A (pt) 2004-12-07
US7128928B2 (en) 2006-10-31
AU2003213210A1 (en) 2003-09-09

Similar Documents

Publication Publication Date Title
AR038575A1 (es) Formulacion oftalmica con nueva composicion de goma
BRPI0611400B1 (pt) formulações contendo xiloglicano muco-adesivas úteis em dispositivos médicos e em formulações farmacêuticas
AR062046A1 (es) Soluciones oftalmicas
BR0116186A (pt) Sistema de gelificação reversìvel para liberação de droga ocular
AR051969A1 (es) Metodos y composiciones que usan compuestos inmunomoduladores para el tratamiento y el manejo de lesiones del sistema nervioso central
PE20081361A1 (es) Composiciones farmaceuticas de clonazepam y metodos de uso de las mismas
BR0212475A (pt) Composições farmacêuticas
ES2570856T3 (es) Composiciones oftálmicas que contienen una combinación sinérgica de dos polímeros
ES2155931T3 (es) Forma de administracion de un agente activo de liberacion prolongada en banda.
AR065073A2 (es) Una formulacion medicamentosa de sistema de matriz que tiene liberacion controlada de un compuesto activo
DE69525634D1 (de) Verwendung und zusammensetzung vom arzneimitteln gegen geschechtlich übertragbare krankheiten
AR048773A1 (es) Sistema de administracion de droga (por ejemplo,dexametasona) para tratar una condicion ocular, implante bio-erosionable de liberacion prolongada comprendido en el anterior y uso de este ultimo para la fabricacion de dicho sistema de administracion de droga
ES2194732T3 (es) Composiciones farmaceuticas orales de liberacion controlada de mesalazina.
BRPI0507683A8 (pt) dose unitária de formulação farmacêutica com liberação controlada, seu processo de preparação e uso de um copolímero de poli(acrilato de etila, metacrilato de metila) neutro
AR047205A1 (es) Composiciones oftalmicas que contienen una combinacion sinergica de tres polimeros
PE20020307A1 (es) Forma de dosificacion de farmaco activada por hidrogel
WO2017212422A1 (en) Topical compositions comprising carbomer for the treatment and prevention of viral infections and allergic conditions
ES2125679T3 (es) Sistema transdermico de administracion simultanea de varios principios activos.
AR018862A1 (es) Formulacion farmaceutica de liberacion prolongada, mejorada para la administracion oral de nefazodona o una sal farmaceuticamente aceptable de la misma;forma de dosificacion oral que la comprende y uso de dicha formulacion para preparar dicha forma de dosificacion
WO2020222139A9 (en) Formulations and methods for drug instillation into the bladder and treatment of bladder ailments
ES2860098T3 (es) Composición para la aplicación nasal
AR052882A1 (es) Composicion antihelmintica
JP2017197524A (ja) 眼科組成物
PE20131337A1 (es) Composicion anestesica nanoparticulada para la administracion topica
ES2150404T1 (es) Composiciones farmaceuticas de tizoxanida y nitozoxanida.

Legal Events

Date Code Title Description
FB Suspension of granting procedure